Other studies have shown that high PML levels correlate with poor prognosis in breast cancer patient sets, and PML KD compromises tumor growth and metastasis (Carracedo et al., 2012; Martin‐Martin et al., 2016; Ponente et al., 2017). This evidence concerns the gene PML and breast carcinoma.